Pratt Laboratory
Pratt Laboratory
Research
Team
Erica
Publications
Join
Resources
BME Jobs List
Other
Contact
Timothy B. Lannin
Latest
Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer
Cite
×